NMRA vs PAYC · $283.5M cap vs P/E 33, rev $1.88B
Neumora Therapeutics, Inc. (NMRA) versus Paycom Soft (PAYC) — a side-by-side from cached financials, not a winner call.
Neumora Therapeutics, Inc. (NMRA) is a biotechnology company listed on NASDAQ.
Paycom Soft (PAYC) is a software - application company listed on US.
NMRA does not have a complete income-statement cache yet.
Latest reported PAYC revenue for 2024-12-31 was $1.88B. Net income was $502.0M. Revenue was up 11.2% from 2023-12-31 to 2024-12-31. PAYC currently screens at market cap $13.06B and trailing P/E 33.1.
NMRA currently screens at market cap $283.5M. PAYC currently screens at market cap $13.06B and trailing P/E 33.1.
Not investment advice. Open the NMRA and PAYC stock pages for the full models.
Not investment advice.